Effects of Wolffia Globosa (Mankai) in Patients Undergoing Bariatric Surgery.
Completed · Not applicable
Conditions studied: Bariatric Surgery Candidate, Diet Modification
In brief
Candidates to bariatric surgery at The Bariatric and Metabolic Institute at Cleveland Clinic Florida are prescribed a high protein liquid diet for two weeks preoperatively and 2 weeks postoperatively. Whether Wolffia Globosa (Mankai), a plant based wholesome food, can serve as a natural alternative to liquid diet during the 2 week pre-operation and 2 weeks postoperation liquid based diet, is unknown. The investigators aim to address the effect of daily Wolffia Globosa (Mankai) administration on morbid/severely-obese patients during the 2 week pre-operative period and 2 weeks postoperatively as compared to iso protein-iso caloric shake source on the following parameters
Key facts
- Study ID
- NCT03999632
- Run by
- Cleveland Clinic Florida
- People needed
- 3
- Starts
- 2019-08-01
- Expected to finish
- 2020-12-01
- Last updated by the study team
- 2021-02-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients that will undergo sleeve gastrectomy.
You may not qualify if…
- Age below 18 years
- American Society of Anesthesiologist (ASA) class IV or V
- Patients using Vitamin-K antagonists
- Patients with documented coagulopathies.
Where it is running
- Cleveland Clinic Florida — Weston, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.